Key Highlights
•
The final results from a large trial testing a combination of two immunotherapy drugs (CTLA-4 and PD-1 inhibitors) showed promising signs of effectiveness across 53 different types of rare cancers that had stopped responding to other treatments. This suggests that this dual immunotherapy approach could become a new treatment option for many patients with rare, hard-to-treat cancers.
Source →
•
A major review of 68 studies found that non-drug interventions like counseling and skills training can significantly reduce anxiety and depression in both cancer patients and their family caregivers in the short term (up to 3 months). This highlights the importance of providing psychological support alongside medical treatment to improve the well-being of everyone affected by a cancer diagnosis.
Source →
•
A large real-world data study found that patients with hypertrophic cardiomyopathy (HCM), a heart muscle condition, have more than twice the risk of developing a serious heart infection called infective endocarditis over five years compared to similar people without HCM. This challenges current medical guidelines, which do not classify HCM patients as high-risk, suggesting they may need different preventive care.
Source →
•
A survey of primary care patients showed that after a brief explanation, 85% were willing to take a simple blood test to check for Alzheimer’s disease biomarkers if their doctor recommended it. This strong patient acceptance is a crucial step for making these new, more accessible diagnostic tools a routine part of early memory care.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
